Literature DB >> 26215712

Oral cavity and oropharyngeal squamous cell carcinoma--an update.

Angela C Chi1, Terry A Day2, Brad W Neville3.   

Abstract

Oral cavity squamous cell carcinoma (OC-SCC) is the most common malignancy of the head and neck (excluding nonmelanoma skin cancer). Recent trends have shown a dramatic rise in the incidence of oropharyngeal squamous cell carcinoma (OP-SCC), with a marked increase in lesions related to human papillomavirus infection. This update presents the latest evidence regarding OC-SCC and OP-SCC. In particular, the authors compare and contrast tumors at these two sites with respect to epidemiology, etiopathogenesis, clinicopathologic presentation, clinical assessment, imaging, management, and prognosis. It is important for clinicians to be aware of differences between OC-SCC and OP-SCC so that appropriate patient education and multidisciplinary care can be provided to optimize outcomes.
© 2015 American Cancer Society.

Entities:  

Keywords:  cancer; human papillomavirus; oral cavity; oropharynx; squamous cell carcinoma

Mesh:

Year:  2015        PMID: 26215712     DOI: 10.3322/caac.21293

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  243 in total

1.  DNA-image cytometry has promise for oral cancer detection.

Authors:  Elliot Abt
Journal:  Evid Based Dent       Date:  2015-12

2.  Prevention of a sexually transmitted disease versus prevention of a serious female cancer: remarkably divergent views of HPV vaccination.

Authors:  Maurie Markman
Journal:  Womens Health (Lond)       Date:  2016-01-12

3.  Are Histomorphological Features Predictive of p16 Immunopositivity Different for Oral and Oropharyngeal Squamous Cell Carcinoma?

Authors:  Aishwary Gayatree; Nadeem Tanveer; Vinod Kumar Arora; Vipin Arora
Journal:  Indian J Surg Oncol       Date:  2020-04-02

4.  Inter- and Intrareader Agreement of NI-RADS in the Interpretation of Surveillance Contrast-Enhanced CT after Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Authors:  F H J Elsholtz; S-R Ro; S Shnayien; C Erxleben; H-C Bauknecht; J Lenk; L-A Schaafs; B Hamm; S M Niehues
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-23       Impact factor: 3.825

5.  Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.

Authors:  Bangrong Cao; Qifeng Wang; Huan Zhang; Guiquan Zhu; Jinyi Lang
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

6.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

7.  Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.

Authors:  Maria B Koenigs; Armida Lefranc-Torres; Juliana Bonilla-Velez; Krupal B Patel; D Neil Hayes; Krzysztof Glomski; Paul M Busse; Annie W Chan; John R Clark; Daniel G Deschler; Kevin S Emerick; Rebecca J Hammon; Lori J Wirth; Derrick T Lin; Edmund A Mroz; William C Faquin; James W Rocco
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

8.  Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.

Authors:  Jau-Song Yu; Yi-Ting Chen; Wei-Fan Chiang; Yung-Chin Hsiao; Lichieh Julie Chu; Lai-Chu See; Chi-Sheng Wu; Hui-Tzu Tu; Hsiao-Wei Chen; Chia-Chun Chen; Wei-Chao Liao; Ya-Ting Chang; Chih-Ching Wu; Che-Yi Lin; Shyun-Yeu Liu; Shu-Ti Chiou; Shu-Li Chia; Kai-Ping Chang; Chih-Yen Chien; Su-Wei Chang; Chee-Jen Chang; John D Young; Chia C Pao; Yu-Sun Chang; Leland H Hartwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

Review 9.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

10.  Noncoding RNAs as effective markers in cancer-care management.

Authors:  Ivan Raimondi; Maite Huarte
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.